Selected research
Market Structure
Global Pharmacovigilance Services and Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmacovigilance Services and Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmacovigilance Services and Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmacovigilance Services and Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmacovigilance Services and Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmacovigilance Services and Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmacovigilance Services and Solutions include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmacovigilance Services and Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmacovigilance Services and Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmacovigilance Services and Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacovigilance Services and Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmacovigilance Services and Solutions Segment by Company
Eurofins Scientific
Accenture
PPD
SGS
WuXi AppTec
Cognizant
ICON
IQVIA
Parexel
United BioSource
Vial
Wipro
PrimeVigilance
Aixial Group
TransPerfect
ProPharma
HCLTech
QbD Group
Quanticate
Qinecsa Solutions
Veristat
Veeda
Tigermed
Clarivate
Pharmacovigilance Services and Solutions Segment by Type
Writing and Submitting Documents and Reports
Security Database System Services and Data Management
Signal Detection and Evaluation
Training and Consulting
Other
Pharmacovigilance Services and Solutions Segment by Application
Preclinical
Clinical Phase
Post-launch
Pharmacovigilance Services and Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Services and Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Services and Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Services and Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacovigilance Services and Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance Services and Solutions industry.
Chapter 3: Detailed analysis of Pharmacovigilance Services and Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance Services and Solutionsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Writing and Submitting Documents and Reports
Table 3. Key Players of Security Database System Services and Data Management
Table 4. Key Players of Signal Detection and Evaluation
Table 3. Key Players of Training and Consulting
Table 4. Key Players of Other
Table 5. Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 6. Key Players of Preclinical
Table 7. Key Players of Clinical Phase
Table 8. Key Players of Post-launch
Table 9. Global Pharmacovigilance Services and Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 10. Global Pharmacovigilance Services and Solutions Market Size by Region (2021-2026) & (US$ Million)
Table 11. Global Pharmacovigilance Services and Solutions Market Share by Region (2021-2026)
Table 12. Global Pharmacovigilance Services and Solutions Market Size by Region (2027-2032) & (US$ Million)
Table 13. Global Pharmacovigilance Services and Solutions Market Share by Region (2027-2032)
Table 14. Pharmacovigilance Services and Solutions Industry Trends
Table 15. Pharmacovigilance Services and Solutions Industry Drivers
Table 16. Pharmacovigilance Services and Solutions Industry Opportunities and Challenges
Table 17. Pharmacovigilance Services and Solutions Industry Restraints
Table 18. Global Pharmacovigilance Services and Solutions Revenue by Company (US$ Million) & (2021-2026)
Table 19. Global Pharmacovigilance Services and Solutions Revenue Market Share by Company (2021-2026)
Table 20. Global Pharmacovigilance Services and Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 21. Global Pharmacovigilance Services and Solutions Key Company Head Office and Area Served
Table 22. Global Pharmacovigilance Services and Solutions Company, Product Type & Application
Table 23. Global Pharmacovigilance Services and Solutions Company Establishment Date
Table 24. Global Company Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pharmacovigilance Services and Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 26. Global Pharmacovigilance Services and Solutions Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 28. Global Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 29. Global Pharmacovigilance Services and Solutions Revenue Market Share by Type (2021-2026)
Table 30. Global Pharmacovigilance Services and Solutions Revenue Market Share by Type (2027-2032)
Table 31. Global Pharmacovigilance Services and Solutions Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 33. Global Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 34. Global Pharmacovigilance Services and Solutions Revenue Market Share by Application (2021-2026)
Table 35. Global Pharmacovigilance Services and Solutions Revenue Market Share by Application (2027-2032)
Table 36. Eurofins Scientific Company Information
Table 37. Eurofins Scientific Business Overview
Table 38. Eurofins Scientific Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 39. Eurofins Scientific Pharmacovigilance Services and Solutions Product Portfolio
Table 40. Eurofins Scientific Recent Development
Table 41. Accenture Company Information
Table 42. Accenture Business Overview
Table 43. Accenture Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 44. Accenture Pharmacovigilance Services and Solutions Product Portfolio
Table 45. Accenture Recent Development
Table 46. PPD Company Information
Table 47. PPD Business Overview
Table 48. PPD Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 49. PPD Pharmacovigilance Services and Solutions Product Portfolio
Table 50. PPD Recent Development
Table 51. SGS Company Information
Table 52. SGS Business Overview
Table 53. SGS Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 54. SGS Pharmacovigilance Services and Solutions Product Portfolio
Table 55. SGS Recent Development
Table 56. WuXi AppTec Company Information
Table 57. WuXi AppTec Business Overview
Table 58. WuXi AppTec Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 59. WuXi AppTec Pharmacovigilance Services and Solutions Product Portfolio
Table 60. WuXi AppTec Recent Development
Table 61. Cognizant Company Information
Table 62. Cognizant Business Overview
Table 63. Cognizant Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 64. Cognizant Pharmacovigilance Services and Solutions Product Portfolio
Table 65. Cognizant Recent Development
Table 66. ICON Company Information
Table 67. ICON Business Overview
Table 68. ICON Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 69. ICON Pharmacovigilance Services and Solutions Product Portfolio
Table 70. ICON Recent Development
Table 71. IQVIA Company Information
Table 72. IQVIA Business Overview
Table 73. IQVIA Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 74. IQVIA Pharmacovigilance Services and Solutions Product Portfolio
Table 75. IQVIA Recent Development
Table 76. Parexel Company Information
Table 77. Parexel Business Overview
Table 78. Parexel Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 79. Parexel Pharmacovigilance Services and Solutions Product Portfolio
Table 80. Parexel Recent Development
Table 81. United BioSource Company Information
Table 82. United BioSource Business Overview
Table 83. United BioSource Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 84. United BioSource Pharmacovigilance Services and Solutions Product Portfolio
Table 85. United BioSource Recent Development
Table 86. Vial Company Information
Table 87. Vial Business Overview
Table 88. Vial Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 89. Vial Pharmacovigilance Services and Solutions Product Portfolio
Table 90. Vial Recent Development
Table 91. Wipro Company Information
Table 92. Wipro Business Overview
Table 93. Wipro Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 94. Wipro Pharmacovigilance Services and Solutions Product Portfolio
Table 95. Wipro Recent Development
Table 96. PrimeVigilance Company Information
Table 97. PrimeVigilance Business Overview
Table 98. PrimeVigilance Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 99. PrimeVigilance Pharmacovigilance Services and Solutions Product Portfolio
Table 100. PrimeVigilance Recent Development
Table 101. Aixial Group Company Information
Table 102. Aixial Group Business Overview
Table 103. Aixial Group Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 104. Aixial Group Pharmacovigilance Services and Solutions Product Portfolio
Table 105. Aixial Group Recent Development
Table 106. TransPerfect Company Information
Table 107. TransPerfect Business Overview
Table 108. TransPerfect Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 109. TransPerfect Pharmacovigilance Services and Solutions Product Portfolio
Table 110. TransPerfect Recent Development
Table 111. ProPharma Company Information
Table 112. ProPharma Business Overview
Table 113. ProPharma Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 114. ProPharma Pharmacovigilance Services and Solutions Product Portfolio
Table 115. ProPharma Recent Development
Table 116. HCLTech Company Information
Table 117. HCLTech Business Overview
Table 118. HCLTech Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 119. HCLTech Pharmacovigilance Services and Solutions Product Portfolio
Table 120. HCLTech Recent Development
Table 121. QbD Group Company Information
Table 122. QbD Group Business Overview
Table 123. QbD Group Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 124. QbD Group Pharmacovigilance Services and Solutions Product Portfolio
Table 125. QbD Group Recent Development
Table 126. Quanticate Company Information
Table 127. Quanticate Business Overview
Table 128. Quanticate Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 129. Quanticate Pharmacovigilance Services and Solutions Product Portfolio
Table 130. Quanticate Recent Development
Table 131. Qinecsa Solutions Company Information
Table 132. Qinecsa Solutions Business Overview
Table 133. Qinecsa Solutions Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 134. Qinecsa Solutions Pharmacovigilance Services and Solutions Product Portfolio
Table 135. Qinecsa Solutions Recent Development
Table 136. Veristat Company Information
Table 137. Veristat Business Overview
Table 138. Veristat Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 139. Veristat Pharmacovigilance Services and Solutions Product Portfolio
Table 140. Veristat Recent Development
Table 141. Veeda Company Information
Table 142. Veeda Business Overview
Table 143. Veeda Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 144. Veeda Pharmacovigilance Services and Solutions Product Portfolio
Table 145. Veeda Recent Development
Table 146. Tigermed Company Information
Table 147. Tigermed Business Overview
Table 148. Tigermed Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 149. Tigermed Pharmacovigilance Services and Solutions Product Portfolio
Table 150. Tigermed Recent Development
Table 151. Clarivate Company Information
Table 152. Clarivate Business Overview
Table 153. Clarivate Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 154. Clarivate Pharmacovigilance Services and Solutions Product Portfolio
Table 155. Clarivate Recent Development
Table 156. North America Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 157. North America Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 158. North America Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 159. North America Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 160. North America Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 161. North America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
Table 162. North America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
Table 163. Europe Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 164. Europe Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 165. Europe Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 166. Europe Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 167. Europe Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 168. Europe Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
Table 169. Europe Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
Table 170. China Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 171. China Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 172. China Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 173. China Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 174. Asia Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 175. Asia Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 176. Asia Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 177. Asia Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 178. Asia Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 179. Asia Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
Table 180. Asia Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
Table 181. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 182. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Type (2027-2032) & (US$ Million)
Table 183. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 184. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Application (2027-2032) & (US$ Million)
Table 185. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 186. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
Table 187. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
Table 188. Research Programs/Design for This Report
Table 189. Authors List of This Report
Table 190. Secondary Sources
Table 191. Primary Sources
List of Figures
Figure 1. Pharmacovigilance Services and Solutions Product Image
Figure 2. Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Pharmacovigilance Services and Solutions Market Share by Type: 2025 VS 2032
Figure 4. Writing and Submitting Documents and Reports Image
Figure 5. Security Database System Services and Data Management Image
Figure 6. Signal Detection and Evaluation Image
Figure 7. Training and Consulting Image
Figure 8. Other Image
Figure 9. Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 10. Global Pharmacovigilance Services and Solutions Market Share by Application: 2025 VS 2032
Figure 11. Preclinical Image
Figure 12. Clinical Phase Image
Figure 13. Post-launch Image
Figure 14. Global Pharmacovigilance Services and Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 15. Global Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 16. Global Pharmacovigilance Services and Solutions Market Share by Region: 2025 VS 2032
Figure 17. Years Considered
Figure 18. Global Pharmacovigilance Services and Solutions Market Share by Players in 2025
Figure 19. Global Top 5 and 10 Pharmacovigilance Services and Solutions Players Market Share by Revenue in 2025
Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. Global Pharmacovigilance Services and Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Pharmacovigilance Services and Solutions Revenue Market Share by Type (2021-2032)
Figure 23. Global Pharmacovigilance Services and Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global Pharmacovigilance Services and Solutions Revenue Market Share by Application (2021-2032)
Figure 25. North America Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 26. North America Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
Figure 27. North America Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
Figure 28. North America Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 29. United States Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 30. Canada Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 31. Mexico Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 32. Europe Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 33. Europe Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
Figure 34. Europe Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
Figure 35. Europe Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 36. Germany Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 37. France Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 38. U.K. Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 39. Italy Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 40. Russia Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 41. Nordic Countries Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 42. China Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 43. China Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
Figure 44. China Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
Figure 45. Asia Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 46. Asia Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
Figure 47. Asia Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
Figure 48. Asia Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 49. Japan Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 50. South Korea Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 51. Taiwan Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 53. India Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 54. Australia Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 55. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 56. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
Figure 57. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
Figure 58. South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
Figure 59. Brazil Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 60. South Africa Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 61. Saudi Arabia Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 62. Turkey Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 63. Argentina Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 64. UAE Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 65. Egypt Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 66. Chile Pharmacovigilance Services and Solutions Market Size (2021-2032) & (US$ Million)
Figure 67. Research Process
Figure 68. Key Executives Interviewed
Scope & coverage.
Types
- Writing and Submitting Documents and Reports
- Security Database System Services and Data Management
- Signal Detection and Evaluation
- Training and Consulting
- Other
Applications
- Preclinical
- Clinical Phase
- Post-launch
Companies covered
- Eurofins Scientific
- Accenture
- PPD
- SGS
- WuXi AppTec
- Cognizant
- ICON
- IQVIA
- Parexel
- United BioSource
- Vial
- Wipro
- PrimeVigilance
- Aixial Group
- TransPerfect
- ProPharma
- HCLTech
- QbD Group
- Quanticate
- Qinecsa Solutions
- Veristat
- Veeda
- Tigermed
- Clarivate
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Writing and Submitting Documents and Reports
- 1.2.3 Security Database System Services and Data Management
- 1.2.4 Signal Detection and Evaluation
- 1.2.5 Training and Consulting
- 1.2.6 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmacovigilance Services and Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Preclinical
- 1.3.3 Clinical Phase
- 1.3.4 Post-launch
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmacovigilance Services and Solutions Growth Trends by Region
- 1.5.1 Global Pharmacovigilance Services and Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmacovigilance Services and Solutions Market Size by Region (2021-2026)
- 1.5.3 Pharmacovigilance Services and Solutions Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmacovigilance Services and Solutions Market Dynamics
- 2.1 Pharmacovigilance Services and Solutions Industry Trends
- 2.2 Pharmacovigilance Services and Solutions Industry Drivers
- 2.3 Pharmacovigilance Services and Solutions Industry Opportunities and Challenges
- 2.4 Pharmacovigilance Services and Solutions Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmacovigilance Services and Solutions Revenue by Company (2021-2026)
- 3.2 Global Pharmacovigilance Services and Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmacovigilance Services and Solutions Key Company Head office and Area Served
- 3.4 Global Pharmacovigilance Services and Solutions Company, Product Type & Application
- 3.5 Global Pharmacovigilance Services and Solutions Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmacovigilance Services and Solutions Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmacovigilance Services and Solutions Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmacovigilance Services and Solutions Tier 1, Tier 2, and Tier 3
4 Pharmacovigilance Services and Solutions Market by Type
- 4.1 Global Pharmacovigilance Services and Solutions Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmacovigilance Services and Solutions Market Size by Type (2021-2032)
- 4.3 Global Pharmacovigilance Services and Solutions Market Size Share by Type (2021-2032)
5 Pharmacovigilance Services and Solutions Market by Application
- 5.1 Global Pharmacovigilance Services and Solutions Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmacovigilance Services and Solutions Market Size by Application (2021-2032)
- 5.3 Global Pharmacovigilance Services and Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eurofins Scientific
- 6.1.1 Eurofins Scientific Company Information
- 6.1.2 Eurofins Scientific Business Overview
- 6.1.3 Eurofins Scientific Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eurofins Scientific Pharmacovigilance Services and Solutions Product Portfolio
- 6.1.5 Eurofins Scientific Recent Developments
- 6.2 Accenture
- 6.2.1 Accenture Company Information
- 6.2.2 Accenture Business Overview
- 6.2.3 Accenture Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Accenture Pharmacovigilance Services and Solutions Product Portfolio
- 6.2.5 Accenture Recent Developments
- 6.3 PPD
- 6.3.1 PPD Company Information
- 6.3.2 PPD Business Overview
- 6.3.3 PPD Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 PPD Pharmacovigilance Services and Solutions Product Portfolio
- 6.3.5 PPD Recent Developments
- 6.4 SGS
- 6.4.1 SGS Company Information
- 6.4.2 SGS Business Overview
- 6.4.3 SGS Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 SGS Pharmacovigilance Services and Solutions Product Portfolio
- 6.4.5 SGS Recent Developments
- 6.5 WuXi AppTec
- 6.5.1 WuXi AppTec Company Information
- 6.5.2 WuXi AppTec Business Overview
- 6.5.3 WuXi AppTec Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 WuXi AppTec Pharmacovigilance Services and Solutions Product Portfolio
- 6.5.5 WuXi AppTec Recent Developments
- 6.6 Cognizant
- 6.6.1 Cognizant Company Information
- 6.6.2 Cognizant Business Overview
- 6.6.3 Cognizant Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Cognizant Pharmacovigilance Services and Solutions Product Portfolio
- 6.6.5 Cognizant Recent Developments
- 6.7 ICON
- 6.7.1 ICON Company Information
- 6.7.2 ICON Business Overview
- 6.7.3 ICON Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ICON Pharmacovigilance Services and Solutions Product Portfolio
- 6.7.5 ICON Recent Developments
- 6.8 IQVIA
- 6.8.1 IQVIA Company Information
- 6.8.2 IQVIA Business Overview
- 6.8.3 IQVIA Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 IQVIA Pharmacovigilance Services and Solutions Product Portfolio
- 6.8.5 IQVIA Recent Developments
- 6.9 Parexel
- 6.9.1 Parexel Company Information
- 6.9.2 Parexel Business Overview
- 6.9.3 Parexel Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Parexel Pharmacovigilance Services and Solutions Product Portfolio
- 6.9.5 Parexel Recent Developments
- 6.10 United BioSource
- 6.10.1 United BioSource Company Information
- 6.10.2 United BioSource Business Overview
- 6.10.3 United BioSource Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 United BioSource Pharmacovigilance Services and Solutions Product Portfolio
- 6.10.5 United BioSource Recent Developments
- 6.11 Vial
- 6.11.1 Vial Company Information
- 6.11.2 Vial Business Overview
- 6.11.3 Vial Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Vial Pharmacovigilance Services and Solutions Product Portfolio
- 6.11.5 Vial Recent Developments
- 6.12 Wipro
- 6.12.1 Wipro Company Information
- 6.12.2 Wipro Business Overview
- 6.12.3 Wipro Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Wipro Pharmacovigilance Services and Solutions Product Portfolio
- 6.12.5 Wipro Recent Developments
- 6.13 PrimeVigilance
- 6.13.1 PrimeVigilance Company Information
- 6.13.2 PrimeVigilance Business Overview
- 6.13.3 PrimeVigilance Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 PrimeVigilance Pharmacovigilance Services and Solutions Product Portfolio
- 6.13.5 PrimeVigilance Recent Developments
- 6.14 Aixial Group
- 6.14.1 Aixial Group Company Information
- 6.14.2 Aixial Group Business Overview
- 6.14.3 Aixial Group Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Aixial Group Pharmacovigilance Services and Solutions Product Portfolio
- 6.14.5 Aixial Group Recent Developments
- 6.15 TransPerfect
- 6.15.1 TransPerfect Company Information
- 6.15.2 TransPerfect Business Overview
- 6.15.3 TransPerfect Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 TransPerfect Pharmacovigilance Services and Solutions Product Portfolio
- 6.15.5 TransPerfect Recent Developments
- 6.16 ProPharma
- 6.16.1 ProPharma Company Information
- 6.16.2 ProPharma Business Overview
- 6.16.3 ProPharma Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 ProPharma Pharmacovigilance Services and Solutions Product Portfolio
- 6.16.5 ProPharma Recent Developments
- 6.17 HCLTech
- 6.17.1 HCLTech Company Information
- 6.17.2 HCLTech Business Overview
- 6.17.3 HCLTech Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 HCLTech Pharmacovigilance Services and Solutions Product Portfolio
- 6.17.5 HCLTech Recent Developments
- 6.18 QbD Group
- 6.18.1 QbD Group Company Information
- 6.18.2 QbD Group Business Overview
- 6.18.3 QbD Group Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 QbD Group Pharmacovigilance Services and Solutions Product Portfolio
- 6.18.5 QbD Group Recent Developments
- 6.19 Quanticate
- 6.19.1 Quanticate Company Information
- 6.19.2 Quanticate Business Overview
- 6.19.3 Quanticate Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Quanticate Pharmacovigilance Services and Solutions Product Portfolio
- 6.19.5 Quanticate Recent Developments
- 6.20 Qinecsa Solutions
- 6.20.1 Qinecsa Solutions Company Information
- 6.20.2 Qinecsa Solutions Business Overview
- 6.20.3 Qinecsa Solutions Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Qinecsa Solutions Pharmacovigilance Services and Solutions Product Portfolio
- 6.20.5 Qinecsa Solutions Recent Developments
- 6.21 Veristat
- 6.21.1 Veristat Company Information
- 6.21.2 Veristat Business Overview
- 6.21.3 Veristat Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 Veristat Pharmacovigilance Services and Solutions Product Portfolio
- 6.21.5 Veristat Recent Developments
- 6.22 Veeda
- 6.22.1 Veeda Company Information
- 6.22.2 Veeda Business Overview
- 6.22.3 Veeda Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Veeda Pharmacovigilance Services and Solutions Product Portfolio
- 6.22.5 Veeda Recent Developments
- 6.23 Tigermed
- 6.23.1 Tigermed Company Information
- 6.23.2 Tigermed Business Overview
- 6.23.3 Tigermed Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.23.4 Tigermed Pharmacovigilance Services and Solutions Product Portfolio
- 6.23.5 Tigermed Recent Developments
- 6.24 Clarivate
- 6.24.1 Clarivate Company Information
- 6.24.2 Clarivate Business Overview
- 6.24.3 Clarivate Pharmacovigilance Services and Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.24.4 Clarivate Pharmacovigilance Services and Solutions Product Portfolio
- 6.24.5 Clarivate Recent Developments
7 North America
- 7.1 North America Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 7.2 North America Pharmacovigilance Services and Solutions Market Size by Type
- 7.2.1 North America Pharmacovigilance Services and Solutions Market Size by Type (2021-2026)
- 7.2.2 North America Pharmacovigilance Services and Solutions Market Size by Type (2027-2032)
- 7.2.3 North America Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
- 7.3 North America Pharmacovigilance Services and Solutions Market Size by Application
- 7.3.1 North America Pharmacovigilance Services and Solutions Market Size by Application (2021-2026)
- 7.3.2 North America Pharmacovigilance Services and Solutions Market Size by Application (2027-2032)
- 7.3.3 North America Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
- 7.4 North America Pharmacovigilance Services and Solutions Market Size by Country
- 7.4.1 North America Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 7.4.3 North America Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 7.4.4 North America Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 8.2 Europe Pharmacovigilance Services and Solutions Market Size by Type
- 8.2.1 Europe Pharmacovigilance Services and Solutions Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmacovigilance Services and Solutions Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
- 8.3 Europe Pharmacovigilance Services and Solutions Market Size by Application
- 8.3.1 Europe Pharmacovigilance Services and Solutions Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmacovigilance Services and Solutions Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
- 8.4 Europe Pharmacovigilance Services and Solutions Market Size by Country
- 8.4.1 Europe Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 9.2 China Pharmacovigilance Services and Solutions Market Size by Type
- 9.2.1 China Pharmacovigilance Services and Solutions Market Size by Type (2021-2026)
- 9.2.2 China Pharmacovigilance Services and Solutions Market Size by Type (2027-2032)
- 9.2.3 China Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
- 9.3 China Pharmacovigilance Services and Solutions Market Size by Application
- 9.3.1 China Pharmacovigilance Services and Solutions Market Size by Application (2021-2026)
- 9.3.2 China Pharmacovigilance Services and Solutions Market Size by Application (2027-2032)
- 9.3.3 China Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 10.2 Asia Pharmacovigilance Services and Solutions Market Size by Type
- 10.2.1 Asia Pharmacovigilance Services and Solutions Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmacovigilance Services and Solutions Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
- 10.3 Asia Pharmacovigilance Services and Solutions Market Size by Application
- 10.3.1 Asia Pharmacovigilance Services and Solutions Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmacovigilance Services and Solutions Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
- 10.4 Asia Pharmacovigilance Services and Solutions Market Size by Country
- 10.4.1 Asia Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmacovigilance Services and Solutions Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst